Metagenomi Therapeutics (MGX) Enterprise Value (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Enterprise Value of -$140.2 million for Q1 2026, up 37.97% year-over-year from -$101.6 million in Q1 2025, and up 12.83% quarter-over-quarter from -$160.8 million in Q4 2025.
Metagenomi Therapeutics (MGX) Enterprise Value (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 4 years of Enterprise Value data on file, last reported at -$140.2 million in Q1 2026.
- Enterprise Value for Q1 2026 came in at -$140.2 million, up 37.97% year-over-year; the trailing twelve-month figure through Mar 2026 was -$140.2 million (up 37.97% YoY), and the FY2025 annual result was -$160.8 million, up 35.24% from the prior year.
- Enterprise Value rose to -$140.2 million in Q1 2026 per MGX's latest filing, from -$160.8 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$51.6 million in Q2 2023 and troughed at -$327.4 million in Q1 2024.
- A 4-year average of -$199.0 million and a median of -$205.0 million in 2025 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2024 and 2026: Enterprise Value slumped 480.7% in 2024, then jumped 37.97% in 2026.
- A 4-year view of Enterprise Value shows it stood at -$271.2 million in 2023, then increased by 8.44% to -$248.3 million in 2024, then surged by 35.24% to -$160.8 million in 2025, then rose by 12.83% to -$140.2 million in 2026.
- Business Quant data shows MGX's Enterprise Value at -$140.2 million in Q1 2026, -$160.8 million in Q4 2025, and -$184.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - | -32.30 Mn |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - | -4.14 Mn |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - | -18.44 Mn |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - | -2.77 Mn |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - | -7.20 Mn |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn | -7.25 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - | -584.73 Mn |
| 10 | Metagenomi Therapeutics | 42.84 Mn | 42.84 Mn | - | -140.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -140.16 Mn |
| Dec 31, 2025 | -160.80 Mn |
| Sep 30, 2025 | -184.11 Mn |
| Jun 30, 2025 | -204.99 Mn |
| Mar 31, 2025 | -225.97 Mn |
| Dec 31, 2024 | -248.31 Mn |
| Sep 30, 2024 | -274.59 Mn |
| Jun 30, 2024 | -299.92 Mn |
| Mar 31, 2024 | -327.41 Mn |
| Dec 31, 2023 | -271.18 Mn |
| Sep 30, 2023 | -101.90 Mn |
| Jun 30, 2023 | -51.65 Mn |
| Mar 31, 2023 | -95.67 Mn |